-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Weight loss drugs (drugs promised to help people lose weight) have a tortuous history, such as the notorious fenen-phen, which was withdrawn from the market in 1997 due to reports of heart valve damage
According to the US Centers for Disease Control and Prevention, approximately 42% of American adults are considered clinically obese because their body mass index is 30 or higher
The army of people who want to lose weight for health or aesthetic reasons is expected to bring huge economic benefits to pharmaceutical companies, because pharmaceutical companies can bring safe and effective weight-loss drugs to the market
Now, a new drug must not only prove that it can keep a person's weight loss by 5-10% within a year, but also must have long-term studies to prove that it is safe
Novo Nordisk’s popular new weight loss drug Wegovy (Semalutide) simulates a hormone that helps regulate blood sugar.
Pharmaceutical companies are exploring other hormone receptor molecules that regulate appetite and energy expenditure